|
Volumn 2, Issue 9, 2013, Pages 1252-1258
|
A light-driven anti-cancer dual-therapeutic cassette enhances solid tumour regression
|
Author keywords
Cascade pathway reaction; Chemotherapy; DNA RNA nanostructure; Doxorubicin; Hyperthermal therapy
|
Indexed keywords
CHEMOTHERAPY;
CONTAINERS;
CONTROLLED DRUG DELIVERY;
DNA;
DRUG PRODUCTS;
GOLD;
LIGANDS;
NANOCRYSTALS;
REGRESSION ANALYSIS;
UROLOGY;
ANTI-CANCER THERAPEUTICS;
BIOLOGICAL REACTION;
DOXORUBICIN;
DRUG DESIGN STRATEGIES;
DRUG-LOADING EFFICIENCY;
HYPERTHERMAL THERAPY;
THERAPEUTIC EFFECTS;
TUMOUR REGRESSIONS;
DISEASES;
A10 RNA APTAMER DNA(40) COMPLEX;
A10 RNA APTAMER DOXORUBICIN DNA(40) COMPLEX;
A10 RNA APTAMER DOXORUBICIN DNA(40) COMPLEX GOLD NANOROD;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
GOLD NANOROD;
NANOROD;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL DESTRUCTION;
CANCER REGRESSION;
CELL STRAIN LNCAP;
CONTROLLED STUDY;
DNA DRUG COMPLEX;
DRUG CYTOTOXICITY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG DOSAGE FORM COMPARISON;
DRUG EFFICACY;
DRUG LOADING EFFICIENCY;
DRUG PENETRATION;
DRUG RELEASE;
DRUG STABILITY;
DRUG TRANSPORT;
ENDOCYTOSIS;
IN VITRO STUDY;
IN VIVO STUDY;
INFRARED RADIATION;
LIGHT TEMPERATURE DRIVEN DRUG DELIVERY SYSTEM;
MALE;
MOUSE;
NEAR INFRARED RADIATION;
NONHUMAN;
PHARMACEUTICS;
PHOTOTHERAPY;
PHOTOTHERMAL ABLATION;
PRIORITY JOURNAL;
PROSTATE CANCER;
TUMOR VOLUME;
CASCADE PATHWAY REACTION;
CHEMOTHERAPY;
DNA/RNA NANOSTRUCTURE;
DOXORUBICIN;
HYPERTHERMAL THERAPY;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
BENZENEACETAMIDES;
CELL LINE;
CELL SURVIVAL;
DNA;
DOXORUBICIN;
DRUG DESIGN;
GOLD;
HUMANS;
HYPERTHERMIA, INDUCED;
LIGHT;
MALE;
METAL NANOPARTICLES;
MICE;
MICE, NUDE;
NANOPARTICLES;
PIPERIDONES;
PROSTATIC NEOPLASMS;
RNA;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 84883718496
PISSN: 21922640
EISSN: 21922659
Source Type: Journal
DOI: 10.1002/adhm.201200471 Document Type: Article |
Times cited : (14)
|
References (27)
|